Moreover, in subgroup analyses of the controls, tirzepatide did not increase the risks of any of these cancers compared to placebo, insulin, or GLP-1RA (Table 3)
Interest in the drugs has expanded beyond metabolic disease as researchers have begun exploring their broader biological effects
Theres also a potential risk of changes in cholesterol levels and irregular heart rhythms, with prolonged or high dose usage
Drug Approvals & Launches 1 min read US FDA approves Teva Pharmaceuticals' generic obesity drug Saxenda, chemically known as liraglutide, belongs to the first generation of GLP-1 drugs, which curb appetite as well as help control blood sugar
Both ER and BRCA1 can bind to an estrogen-responsive element like site (EREL) in the IGF-1 promoter, thus enhancing or suppressing IGF-1 expression respectively [5]
Its endocrine role is essential in regulating blood glucose levels, primarily through the secretion of insulin and glucagon